[IMMUNOLOGIC MONITORING OF HELICOBACTER PYLORI PERSISTENCE IN THE ORGANISM]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|October 17, 2015
PubMed

Insights

This 15-year study tracked Helicobacter pylori antigens like CagA and VacA in patients and volunteers. It reveals how these bacterial components interact with the host immune system, impacting disease risk and prognosis.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Helicobacter pylori is a significant pathogen causing gastrointestinal diseases.
  • Understanding the long-term dynamics of H. pylori antigens and host immune responses is crucial.

Purpose of the Study:

  • To investigate the frequency, circulation, and dynamics of key H. pylori antigens (LPS/O-antigens, high molecular weight proteins like CagA and VacA).
  • To analyze the reciprocal immune reactions in the host.
  • To establish the relationship between antigen-host interaction and the risk/prognosis of complications during chronic H. pylori infection.

Main Methods:

  • Prospective longitudinal study over 15 years.
  • Monitoring of pathogenetically significant H. pylori antigens (LPS/O-antigens, CagA, VacA) in biological media.
  • Assessment of host immune responses.
  • Analysis of correlations between antigen dynamics, immune reactions, and clinical outcomes in patients and asymptomatic volunteers.

Main Results:

  • Detailed data on the occurrence and circulation patterns of H. pylori antigens over 15 years.
  • Characterization of host immune responses to specific H. pylori antigens.
  • Established correlations between antigen-host interactions and the risk and prognosis of gastrointestinal diseases.
  • Identified features reflecting the parasite-host tandem dynamics.

Conclusions:

  • The long-term dynamics of H. pylori antigens and host immune responses are critical for understanding disease pathogenesis.
  • Antigen circulation and immune reactions provide insights into the risk and prognosis of complications associated with chronic H. pylori infection.
  • This research contributes to predicting and managing H. pylori-related gastrointestinal conditions.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
787
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
30
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
646
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K